Update on the treatment of thyroid-associated ophthalmopathy with glucocorticoid
- VernacularTitle:糖皮质激素治疗甲状腺相关眼病的新认识
- Author:
Chao LIU
- Publication Type:Journal Article
- Keywords:
Thyroid-associated ophthalmopathy;
Glucocorticoids;
Methylprednisolone;
Pulse therapy;
intravenous
- From:
Chinese Journal of Endocrinology and Metabolism
2000;0(06):-
- CountryChina
- Language:Chinese
-
Abstract:
Thyroid-associated ophthalmopathy(TAO)is an organ specific autoimmune disorder affecting the life quality of patients.Glucocorticoids have been applied for many years in the treatment of TAO,though the side effects are the major concern.Recently,intravenous methylprednisolone pulse therapy is a novel and effective method for TAO treatment.Nevertheless this new strategy needs to be modified,and attention should be paid to the indications and contraindications in order to prevent liver damage when high dose methylprednisolone is applied.
